Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TGTX
#1195
TG Therapeutics, Inc.
30.0
9
-0.36%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.36%
Variazione Mensile
-2.37%
Variazione di 6 mesi
+5.28%
Variazione Annuale
+6.33%
Chiusura Precedente
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
Volume
136
Mercati
Mercato Azionario Statunitense
Salute
TGTX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
—
Valuation ratios
Enterprise value
6.76 B
2.41 B
1.59 B
2.54 B
4.55 B
21.92 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
466.05
Price to sales ratio
—
—
562.55
10.83
14.67
54.61
Price to cash flow ratio
—
—
8.89
80.56
119.11
405.93
Price to book ratio
—
—
0.5
15.77
21.7
39.82
Enterprise value to EBITDA ratio
—
—
—
121.78
108.29
330.68
Profitability ratios
Return on assets %
0.45
0.92
1.02
0.04
0.04
0.43
Return on equity %
0.54
1.47
3.39
0.08
0.11
0.78
Return on invested capital %
1 649.24
2 168.43
1 554.62
145.45
108.67
-220.6
Gross margin %
100
100
100
93.95
88.3
342.12
Operating margin %
180 K
5 154.28
6 924.2
8.83
12.74
60.52
EBITDA margin %
—
—
—
8.92
12.76
77.7
Net margin %
183.8 K
5 204.08
7 121.54
5.42
7.11
267.66
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
13.91
Current ratio
6.99
5.06
3.16
5.92
6.25
17.96
Inventory turnover
—
—
—
0.35
0.51
0.58
Asset turnover
0
0.01
0.01
0.89
0.73
0.78
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.18
0.37
0.3
0.42
1.38
Long term debt to total equity ratio
0
0.02
0.02
0.62
1.1
3.42
Per share metrics
Operating cash flow per share
—
—
1.3
0.21
0.25
0.43
EBIT per share
—
—
—
0.14
0.26
0.64
EBITDA per share
—
—
—
0.14
0.26
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
1.29
1.46
1.94
6.46
Net current asset value per share
—
—
1.24
2.14
3.53
15.3
Tangible book value per share
—
—
22.98
1.08
1.39
8.32
Working capital per share
—
—
0.85
1.78
2.97
11.72
Book value per share
—
—
22.99
1.08
1.39
8.32
Notizie
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG kazancı $0,23 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG Therapeutics, ACTRIMS forumunda BRIUMVI verilerini sundu
TG Therapeutics presents BRIUMVI data at ACTRIMS forum
TG Therapeutics hissesi, güçlü Briumvi büyümesiyle B.Riley’den Al notunu korudu
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
TG Therapeutics, ACTRIMS forumunda BRIUMVI verilerini sunacak